Gestational Trophoblastic Disease (GTD)

Gestational trophoblastic disease (GTD) is a rare condition that arises in the placenta. Cancer begins when normal cells begin to change and grow uncontrollably, forming a mass called a tumour. A tumour can be benign (noncancerous) or malignant (cancerous, meaning it can spread to other parts of the body.) A Gestational Trophoblastic Tumour (GTT) is most commonly the result of a pregnancy with an abnormal combination of a sperm and egg. In other cases, a GTT is a cancerous growth that begins from a normal placenta. The placenta is the organ that develops during pregnancy and connects the fetus (unborn baby) to the uterus, also called the womb.

For further information, please click on the links below or visit the Charing Cross GTD website here

Immunotherapy Trial for Gestational Trophoblastic Disease

We are currently trying to develop ways to avoid the use of toxic multi-drug chemotherapy to treat GTD by running a trial of immunotherapy treatment instead.

Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. It helps your immune system to recognise and fight cancer cells. It can educate the immune system to recognize and attack specific cancer cells and boost immune cells to help them eliminate cancer.

This trial will cost £1 million to run and so we need your help to raise funds to enable the trial to go ahead. Please click below to read full details about the trial and how you can get involved and donate